13G filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP and 3 other reporting persons reported 4,457,450 SYRE shares, 5.1% of the class, as of 2026-09-24, in a 13G accepted by EDGAR 2026-10-01 20:05:36 UTC.
- Accession
- 0001104659-26-112828
- Filer
- CIK 1855655
- Filed
- 2026-10-01
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Shares
- 4,457,450
- Percent of class
- 5.1%
- Event date
- 2026-09-24
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group Paradigm Biocapital Advisors LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | PN | 4,457,450 | 0 | 4,457,450 | 0 | 4,457,450 | 5.1% |
| Paradigm BioCapital Advisors GP LLC | OO | 4,457,450 | 0 | 4,457,450 | 0 | 4,457,450 | 5.1% |
| Senai Asefaw, M.D. | IN | 4,457,450 | 0 | 4,457,450 | 0 | 4,457,450 | 5.1% |
| Paradigm BioCapital International Fund Ltd. | CO | 3,928,646 | 0 | 3,928,646 | 0 | 3,928,646 | 4.5% |